Prot #GTX-104-003: Safety and Tolerability of GTX-104 (Nimodipine Injection for IV Infusion) Compared with Oral Nimodipine in Patients Hospitalized for Aneurysmal Subarachnoid Hemorrhage (aSAH): a Prospective, Randomized Trial

Project: Research project

Project Details

StatusActive
Effective start/end date1/9/24 → 1/9/27

Funding

  • WuXi Clinical Development, Inc (Prot #GTX-104-003 // Prot #GTX-104-003)
  • Acasti Pharma, Inc. (Prot #GTX-104-003 // Prot #GTX-104-003)